The therapy also resulted in a significant reduction in MDSCs, the activation and maturation of DCs, and the polarization of M1 macrophage, which are essential for CD4+ T cell-mediated, adaptive, and durable anti-tumor immunity [24]. This evidence concerns the gene CD4 and neoplasm.